Raaj Medisafe India Limited (RAAJMEDI.BO)
INR 85.0
(0.0%)
INR 85.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 42.74 Million | 1.73 Million | 24.45 Million | 22.28 Million | -10.26 Million | -13.74 Million |
| Net Income | 43.05 Million | 37.82 Million | 37.27 Million | 25.8 Million | -13.79 Million | -15.92 Million |
| Depreciation & Amortization | 8.37 Million | 7.52 Million | 7.23 Million | 7.11 Million | 3.17 Million | 3.11 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -17.01 Million | -48.23 Million | -28.18 Million | -18.49 Million | -9.04 Million | 1.31 Million |
| Other non-cash items | 15.05 Million | 4.63 Million | 8.12 Million | 7.86 Million | 9.4 Million | -2.25 Million |
| Investing Cash Flow | -130 Million | -16.65 Million | -9.61 Million | -27.8 Million | -2.12 Million | -546.48 Thousand |
| Investments in PPE | -116.39 Million | -17.26 Million | -12.1 Million | -38.88 Million | -2.18 Million | -3.25 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 444 Thousand | 608.62 Thousand | 2.48 Million | 11.08 Million | 58 Thousand | 2.71 Million |
| Financing Cash Flow | 87.43 Million | 14.85 Million | -14.66 Million | 5.13 Million | 12.38 Million | 14.28 Million |
| Debt repayment | -103.08 Million | -11.96 Million | -30.08 Million | -6.28 Million | -16.98 Million | -17.58 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | 14.85 Million | 15.41 Million | 5.13 Million | 12.38 Million | -3.29 Million |
| Accounts receivables | -12.63 Million | -14.1 Million | -5.38 Million | -2 Million | -8.21 Million | -439.7 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -18.52 Million | -35.02 Million | -15.86 Million | -6.51 Million | -1.48 Million | 1.01 Million |
| Other working capital | 14.84 Million | 900.93 Thousand | -6.93 Million | -9.98 Million | 654.99 Thousand | 745.8 Thousand |
| Cash at beginning of period | 265 Thousand | 323 Thousand | 149 Thousand | 532 Thousand | 68 Thousand | 69.6 Thousand |
| Cash at end of period | 442 Thousand | 265.06 Thousand | 323 Thousand | 149 Thousand | 64 Thousand | 68.06 Thousand |
| Capital Expenditure | -116.39 Million | -17.26 Million | -12.1 Million | -38.88 Million | -2.18 Million | -3.25 Million |
| Effect of forex changes on cash | - | - | 500.00 | 468 Thousand | -1060.00 | 10.00 |
| Net cash flow / Change in cash | 177 Thousand | -57.94 Thousand | 174 Thousand | -383 Thousand | -4000.00 | -1540.00 |
| Free Cash Flow | -73.64 Million | -15.52 Million | 12.34 Million | -16.6 Million | -12.44 Million | -17 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2022 FY | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 43.05 Million | 9.39 Million | 10.55 Million | 6.34 Million | 37.82 Million | 5.64 Million |
| Depreciation & Amortization | 8.37 Million | - | - | - | 7.52 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -17.01 Million | - | - | - | -48.23 Million | - |
| Other non-cash items | 15.05 Million | -9.39 Million | -10.55 Million | -6.34 Million | 4.63 Million | -5.64 Million |
| Investing Cash Flow | -130 Million | - | - | - | -16.65 Million | - |
| Investments in PPE | -116.39 Million | - | - | - | -17.26 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 444 Thousand | - | - | - | 608.62 Thousand | - |
| Financing Cash Flow | 87.43 Million | - | - | - | 14.85 Million | - |
| Debt repayment | -103.08 Million | - | - | - | -11.96 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1000.00 | - | - | - | 14.85 Million | - |
| Accounts receivables | -12.63 Million | - | - | - | -14.1 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -18.52 Million | - | - | - | -35.02 Million | - |
| Other working capital | 14.84 Million | - | - | - | 900.93 Thousand | - |
| Cash at beginning of period | 265 Thousand | - | - | - | 323 Thousand | - |
| Cash at end of period | 442 Thousand | - | - | - | 265.06 Thousand | - |
| Capital Expenditure | -116.39 Million | - | - | - | -17.26 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 177 Thousand | - | - | - | -57.94 Thousand | - |
| Free Cash Flow | -73.64 Million | - | - | - | -15.52 Million | - |
ADDDF
DEUZF
SLS
GORV
WCHS
CEPS